Fennec Pharmaceuticals Statistics

Total Valuation

FENC has a market cap or net worth of $164.18 million. The enterprise value is $156.89 million.

Market Cap	164.18M
Enterprise Value	156.89M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, before market open.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

FENC has 27.59 million shares outstanding. The number of shares has increased by 2.71% in one year.

Current Share Class	27.59M
Shares Outstanding	27.59M
Shares Change (YoY)	+2.71%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	28.11%
Float	14.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	87.50
PS Ratio	3.42
Forward PS	3.15
PB Ratio	-27.96
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	6.09
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.30
EV / EBITDA	43.58
EV / EBIT	61.09
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.38

Current Ratio	6.38
Quick Ratio	5.71
Debt / Equity	n/a
Debt / EBITDA	5.37
Debt / FCF	n/a
Interest Coverage	0.62

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	4.47%
Return on Invested Capital (ROIC)	9.79%
Return on Capital Employed (ROCE)	6.75%
Revenue Per Employee	$1.49M
Profits Per Employee	-$13,625
Employee Count	32
Asset Turnover	1.32
Inventory Turnover	1.98

Taxes

In the past 12 months, FENC has paid $365,000 in taxes.

Income Tax	365,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.81% in the last 52 weeks. The beta is 0.32, so FENC's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-35.81%
50-Day Moving Average	6.02
200-Day Moving Average	5.70
Relative Strength Index (RSI)	51.32
Average Volume (20 Days)	50,960

Short Selling Information

The latest short interest is 1.44 million, so 5.21% of the outstanding shares have been sold short.

Short Interest	1.44M
Short Previous Month	1.50M
Short % of Shares Out	5.21%
Short % of Float	9.98%
Short Ratio (days to cover)	14.34

Income Statement

In the last 12 months, FENC had revenue of $47.54 million and -$436,000 in losses. Loss per share was -$0.02.

Revenue	47.54M
Gross Profit	44.35M
Operating Income	2.57M
Pretax Income	3.75M
Net Income	-436,000
EBITDA	3.60M
EBIT	2.57M
Loss Per Share	-$0.02

Full Income Statement

Balance Sheet

The company has $26.63 million in cash and $19.34 million in debt, giving a net cash position of $7.29 million or $0.26 per share.

Cash & Cash Equivalents	26.63M
Total Debt	19.34M
Net Cash	7.29M
Net Cash Per Share	$0.26
Equity (Book Value)	-5.87M
Book Value Per Share	-0.21
Working Capital	37.21M

Full Balance Sheet

Cash Flow

Operating Cash Flow	26.98M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 93.30%, with operating and profit margins of 5.40% and -0.92%.

Gross Margin	93.30%
Operating Margin	5.40%
Pretax Margin	-0.15%
Profit Margin	-0.92%
EBITDA Margin	7.57%
EBIT Margin	5.40%
FCF Margin	n/a

Dividends & Yields

FENC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.71%
Shareholder Yield	n/a
Earnings Yield	-0.27%
FCF Yield	n/a

Analyst Forecast

The average price target for FENC is $14.00, which is 135.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	135.29%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	29.44%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 5, 2014. It was a reverse split with a ratio of 0.3333333:1.

Last Split Date	Sep 5, 2014
Split Type	Reverse
Split Ratio	0.3333333:1

Scores

FENC has an Altman Z-Score of -2.26 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.26
Piotroski F-Score	6